Despite her dominant effort opposite Jessica Aguilar at UFC 211 in Dallas, Texas, earlier this month, women’s strawweight fighter Cortney Casey will have her unanimous decision victory overturned to a no-contest after failing an in-competition drug test on May 13 for elevated levels of testosterone, per a recent report by MMA Fighting.

According to Casey’s test results, which were obtained by MMA Fighting earlier today (Fri., May 26, 2017) via an open records request with the Texas Department of Licensing and Regulation (TDLR), her testosterone-to-epitestosterone ratio was 5.4:1, which is over the Texas limit of 4:1.

While TDLR does offer follow-up tests for fighters who disclose taking a substance that may elevate testosterone levels, Casey has not disclosed anything. Therefore, she’’ll have her win overturned to a no-contest, get suspended three months in the Association of Boxing Commissions and Combative Sports’ (ABC) database, and fined $2,000 under Texas rule.

Luckily, the 30-year-old strawweight will not be facing any sanctions by United States Anti-Doping Agency (USADA), per a statement made by UFC vice president of health and performance Jeff Novitzky to MMA Fighting.

“We have not been informed by USADA of anything regarding a potential anti-doping policy violation for Cortney Casey,” said Novitzky. “No positive tests, no suspicion of anything — now or in the past. USADA has not been in contact with us about anything at all related to that.”